- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | EQS-News: NeuroOne Medical Technologies: NeuroOne(R) to Report Third Quarter Fiscal Year 2026 Financial Results on Thursday, August 13, 2026, at 8:30 a.m. Eastern Time | 226 | EQS Group (EN) | EQS-News: NeuroOne Medical Technologies
/ Key word(s): Financial
NeuroOne(R) to Report Third Quarter Fiscal Year 2026 Financial Results on Thursday, August 13, 2026, at 8:30 a.m.... ► Artikel lesen | |
| Do | EQS-News: NeuroOne Medical Technologies: NeuroOne Releases CNS Drug Delivery White Paper Ahead of Planned Fiscal Year-End Availability of the StereoCED Platform | 359 | EQS Group (EN) | EQS-News: NeuroOne Medical Technologies
/ Key word(s): Science
NeuroOne Releases CNS Drug Delivery White Paper Ahead of Planned Fiscal Year-End Availability of the StereoCED Platform... ► Artikel lesen | |
| 28.07. | EQS-News: NeuroOne Medical Technologies: NeuroOne(R) Highlights Potential Paradigm Shift for Patients Treated With the OneRF(R) Brain Ablation System Based on Reports by Physicians | 313 | EQS Group (EN) | EQS-News: NeuroOne Medical Technologies
/ Key word(s): Financial
NeuroOne(R) Highlights Potential Paradigm Shift for Patients Treated With the OneRF(R) Brain Ablation System Based... ► Artikel lesen | |
| 16.07. | EQS-News: NeuroOne Medical Technologies: NeuroOne(R) Expands Drug Delivery Program Through Collaboration on Pediatric Brain Cancer Clinical Trial | 390 | EQS Group (EN) | EQS-News: NeuroOne Medical Technologies
/ Key word(s): Financial
NeuroOne(R) Expands Drug Delivery Program Through Collaboration on Pediatric Brain Cancer Clinical Trial 16.07.2026... ► Artikel lesen | |
| 29.06. | EQS-News: NeuroOne Medical Technologies: NeuroOne(R) Added to Russell Microcap(R) Index | 347 | EQS Group (EN) | EQS-News: NeuroOne Medical Technologies
/ Key word(s): Financial
NeuroOne(R) Added to Russell Microcap(R) Index 29.06.2026 / 14:35 CET/CEST
The issuer is solely responsible... ► Artikel lesen | |
| 25.06. | EQS-News: NeuroOne Medical Technologies: NeuroOne(R) Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | 390 | EQS Group (EN) | EQS-News: NeuroOne Medical Technologies
/ Key word(s): Financial
NeuroOne(R) Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) 25.06.2026 / 23:03 CET/CEST
The issuer... ► Artikel lesen | |
| 16.06. | EQS-News: NeuroOne Medical Technologies: NeuroOne(R) Announces Preliminary Inclusion in Russell Microcap(R) Index | 375 | EQS Group (EN) | EQS-News: NeuroOne Medical Technologies
/ Key word(s): Science
NeuroOne(R) Announces Preliminary Inclusion in Russell Microcap(R) Index 16.06.2026 / 14:35 CET/CEST
The issuer... ► Artikel lesen | |
| 12.06. | NEUROONE MEDICAL TECHNOLOGIES Corp - 8-K, Current Report | 2 | SEC Filings | ||
| NEUROONE MEDICAL TECHNOLOGIES Aktie jetzt für 0€ handeln | |||||
| 12.06. | NEUROONE MEDICAL TECHNOLOGIES Corp - 10-Q/A, Quarterly Report | 2 | SEC Filings | ||
| 08.06. | EQS-News: NeuroOne Medical Technologies: NeuroOne(R) to Present at the Planet MicroCap Las Vegas 2026 Conference Wednesday, June 17, 2026 at 12:00 p.m. Pacific Time | 342 | EQS Group (EN) | EQS-News: NeuroOne Medical Technologies
/ Key word(s): Financial
NeuroOne(R) to Present at the Planet MicroCap Las Vegas 2026 Conference Wednesday, June 17, 2026 at 12:00 p.m.... ► Artikel lesen | |
| 28.05. | EQS-News: NeuroOne Medical Technologies: NeuroOne(R) to Present at the 2026 American Society for Stereotactic and Functional Neurosurgery Biennial Meeting on May 31, 2026 | 391 | EQS Group (EN) | EQS-News: NeuroOne Medical Technologies
/ Key word(s): Financial
NeuroOne(R) to Present at the 2026 American Society for Stereotactic and Functional Neurosurgery Biennial Meeting... ► Artikel lesen | |
| 22.05. | EQS-News: NeuroOne Medical Technologies: NeuroOne(R) Medical Technologies Announces Restatement of Financial Results for Quarter Ending March 31, 2026 | 529 | EQS Group (EN) | EQS-News: NeuroOne Medical Technologies
/ Key word(s): Financial
NeuroOne(R) Medical Technologies Announces Restatement of Financial Results for Quarter Ending March 31, 2026... ► Artikel lesen | |
| 22.05. | NEUROONE MEDICAL TECHNOLOGIES Corp - 8-K, Current Report | 1 | SEC Filings | ||
| 18.05. | Trotz verfehlter Q2-Prognosen: NeuroOne-Aktie im Aufwind | 4 | Investing.com Deutsch | ||
| 12.05. | NeuroOne Medical Tech Q2 2026 Earnings Call Transcript | 1 | Benzinga.com | ||
| 12.05. | NeuroOne Medical Technologies GAAP EPS of -$0.25 misses by $0.02, revenue of $2.4M misses by $0.18M | 1 | Seeking Alpha | ||
| 12.05. | NeuroOne outlines ISO 13485 certification in latter part of 2026 while targeting drug delivery availability in second half of fiscal 2026 | 2 | Seeking Alpha | ||
| 12.05. | NeuroOne verfehlt Q2-Prognosen: Aktie gibt nach | 1 | Investing.com Deutsch | ||
| 12.05. | EQS-News: NeuroOne Medical Technologies: NeuroOne Reports Fiscal Q2 2026 Financial Results and Provides Corporate Business Update | 1.484 | EQS Group (EN) | EQS-News: NeuroOne Medical Technologies
/ Key word(s): Financial
NeuroOne Reports Fiscal Q2 2026 Financial Results and Provides Corporate Business Update 12.05.2026 / 14:03 CET/CEST
The... ► Artikel lesen | |
| 12.05. | NEUROONE MEDICAL TECHNOLOGIES Corp - 10-Q, Quarterly Report | 1 | SEC Filings |
1 2 3 Weiter >>
45 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| CERENOME | 3,450 | 0,00 % | Plus Therapeutics Inc.: Cerenome Launches as an Integrated CNS Oncology Company | HOUSTON, July 31, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the "Company"), today announces that its corporate rebrand to Cerenome will be completed as scheduled. Effective... ► Artikel lesen | |
| ORGANON | 11,725 | -0,26 % | Organon: $81 Million Jada Gain Lifts GAAP Profit 68% As Adjusted Earnings Fall 29% | ||
| QUIDELORTHO | 15,355 | +0,75 % | QuidelOrtho Corporation: QuidelOrtho Appoints Micah Young as Chief Financial Officer | Seasoned medical technology finance executive brings more than two decades of leadership at global public companies SAN DIEGO, June 23, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq:... ► Artikel lesen | |
| NANO-X IMAGING | 1,015 | -5,14 % | Nano-X Imaging Q2 2026 Earnings Preview | ||
| ROCKWELL MEDICAL | 7,300 | -3,57 % | XFRA RWM: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILROCKWELL MEDICAL... ► Artikel lesen | |
| NUWELLIS, INC | 1,700 | -9,57 % | Morning Market Movers: Nuwellis, T3 Defense, Capricor Therapeutics, PN Smart Energy See Big Swings | DEERFIELD (dpa-AFX) - At 8:45 a.m. ET on Thursday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 18,660 | +2,08 % | Jefferies senkt Kursziel für Procept BioRobotics nach verfehlten Eingriffszahlen | ||
| NEURONETICS | 2,040 | +2,26 % | Neuronetics and Jorey Chernett Announce Shared Vision | ||
| PULSE BIOSCIENCES | 32,000 | -3,61 % | Biotech Stocks At 52-Week Highs - INCY Rises With Q2 Results, PLSE, SI, BVS, LBRX | WASHINGTON (dpa-AFX) - The following biotech stocks reached a 52-week high on July 28, 2026, driven by key catalysts including positive quarterly results.Incyte Corporation (INCY)Incyte is a... ► Artikel lesen | |
| OPTIMIZERX | 6,920 | +1,02 % | OptimizeRx Corporation: OptimizeRx Appoints Veteran Point of Care Marketing Leader Sarah Bast as Chief Marketing Officer | WALTHAM, Mass., July 23, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the "Company") (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage... ► Artikel lesen | |
| PAVMED | 4,190 | -8,62 % | PAVmed Inc.: PAVmed Provides Business Update and Reports First Quarter 2026 Financial Results | Veris Health progressed commercial expansion and advanced implantable physiological monitor development toward FDA submission
Lucid Diagnostics continued building... ► Artikel lesen | |
| ORTHOFIX MEDICAL | 10,300 | -0,96 % | Orthofix Medical beats top-line and bottom-line estimates; updates FY26 outlook | ||
| OWLET | 5,495 | +2,90 % | Owlet Announces New $25 Million Credit Facility With Wells Fargo | ||
| QTREX QUANTUM | 1,080 | +2,86 % | QTREX Quantum Ltd. - 6-K, Report of foreign issuer | ||
| PICARD MEDICAL | 3,720 | -13,49 % | Picard Medical, Inc.: Picard Medical / SynCardia Presents Emperor Total Artificial Heart Architecture for the First Time at IEEE EMBC 2026 |
Das Unternehmen NEUROONE MEDICAL TECHNOLOGIES CORPORATION kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von -0,050 (-2,96 %) liegt der Kurs bei 1,640 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu NEUROONE MEDICAL TECHNOLOGIES CORPORATION finden Sie auf Wallstreet Online.